Skip to Content

ProQR Therapeutics NV PRQR

Morningstar Rating
$2.29 −0.09 (3.79%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PRQR is trading at a 32% discount.
Price
$2.38
Fair Value
$1.53
Uncertainty
Extreme
1-Star Price
$75.99
5-Star Price
$6.64
Economic Moat
Xtyn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PRQR is a good fit for your portfolio.

Trading Information

Previous Close Price
$2.38
Day Range
$2.232.47
52-Week Range
$1.113.29
Bid/Ask
$2.19 / $2.43
Market Cap
$186.29 Mil
Volume/Avg
109,180 / 325,396

Key Statistics

Price/Earnings (Normalized)
Price/Sales
26.32
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
157

Comparables

Valuation

Metric
PRQR
SGMO
QURE
Price/Earnings (Normalized)
Price/Book Value
4.071.441.20
Price/Sales
26.320.6615.65
Price/Cash Flow
Price/Earnings
PRQR
SGMO
QURE

Financial Strength

Metric
PRQR
SGMO
QURE
Quick Ratio
3.511.728.44
Current Ratio
3.541.988.85
Interest Coverage
−24.28−6.85
Quick Ratio
PRQR
SGMO
QURE

Profitability

Metric
PRQR
SGMO
QURE
Return on Assets (Normalized)
−20.14%−22.55%−35.54%
Return on Equity (Normalized)
−71.25%−35.70%−82.34%
Return on Invested Capital (Normalized)
−43.03%−34.64%−55.12%
Return on Assets
PRQR
SGMO
QURE
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRMnnyznsphbQywjl$570.1 Bil
VRTX
Vertex Pharmaceuticals IncTzlrnpjkRywpgbr$108.0 Bil
REGN
Regeneron Pharmaceuticals IncVhbwqdvwcVcmsvyj$105.6 Bil
MRNA
Moderna IncQzbzhnmBlrbn$40.8 Bil
ARGX
argenx SE ADRRtbszcbXcm$23.5 Bil
BNTX
BioNTech SE ADRYzcrxjxttTmv$21.9 Bil
ALNY
Alnylam Pharmaceuticals IncXcmcylmfJtyxzh$18.8 Bil
BMRN
Biomarin Pharmaceutical IncVtmjjcjgXtydsq$16.5 Bil
RPRX
Royalty Pharma PLC Class ATnktczlkXqqdpms$13.6 Bil
INCY
Incyte CorpDlbkqkgjHjzqrhp$12.8 Bil

Sponsor Center